Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus. - Abstract - Europe PMC
Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series | Journal of Medical Case Reports | Full Text
Tolerability Profile of JANUVIA® (sitagliptin) When Added to Metformin vs Metformin Alone
Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink
IJMS | Free Full-Text | Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model | HTML
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
Sitagliptin (Januvia) and Saxagliptin (Onglyza) (DPP-4 Inhibitors) for Nursing RN
Metformin—mode of action and clinical implications for diabetes and cancer | Nature Reviews Endocrinology
Hypothesised anti-fibrotic mechanisms activated in sitagliptin-or... | Download Scientific Diagram
Summary table of mechanism of action, side effect and ... | GrepMed
Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice - ScienceDirect
Sitagliptin Compared with Thiazolidinediones as a Third-Line Oral Antihyperglycemic Agent in Type 2 Diabetes Mellitus - Endocrine Practice
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect | HTML
Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway | Cell Death Discovery
Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action
NEW DIABETES TREATMENTS - ppt download
Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library
Mechanism of Action | JANUVIA® (sitagliptin)
Sitagliptin Phosphate Monohydrate
Sitagliptin
Frontiers | Clinical Use of DPP-4 Inhibitors | Endocrinology
البورد العراقي للصيدلة السريرية - 🔵Dipeptidyl peptidase-4 inhibitors🔵 💊Alogliptin, 💊linagliptin, 💊saxagliptin, and 💊sitagliptin are 👌oral dipeptidyl peptidase-4 (DPP-4) inhibitors used for the treatment of type 2 diabetes. ⚙ Mechanism of action ...